3D Bioprinting Global Market Report 2022: Advancements in Technology, Increasing R&D Expenditure, and Rising Disposable Income to Fuel Growth - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 28, 2022--
The "3D Bioprinting Market Analysis by Technology (Magnetic Levitation, Inkjet-Based, Laser-Based, Syringe-Based), by Application (Medical, Dental, Biosensors, Bio-Inks, Consumer Product Testing, Food & Animal Product), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The global 3D bioprinting market size is estimated to be USD 1,745.2 million in 2021 and is expected to witness a CAGR of 21.75% during the forecast period. Rising geriatric population with chronic illness cases is a key driver for the growth of the global 3D bioprinting market. Additionally, the advancements in technology, increasing R&D expenditure, and rising disposable income are some of the other drivers propelling the market growth. Nevertheless, the expensive cost of technology and un-skilled personnel are expected to restrain the global market growth.
Market Segmentation
3D Bioprinting Market, By Technology (Revenue, USD Million, 2021 - 2029)
- Magnetic Levitation
- Inkjet-based
- Laser-based
- Syringe-based
- Others
3D Bioprinting Market, By Application (Revenue, USD Million, 2021 - 2029)
Medical
- Medical pills
- Tissue and organ generation
- Prosthetics and implants
- Biosensors
- Dental
- Consumer/Personal Product Testing
- Food and Animal Product
- Bio inks
3D Bioprinting Market, By Region (Revenue, USD Million, 2021 - 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: 3D Bioprinting
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: 3D Bioprinting Market
7. Market Analysis by Technology
8. Market Analysis by Application
9. Regional Market Analysis
10. North America 3D Bioprinting Market
11. Europe 3D Bioprinting Market
12. Asia Pacific 3D Bioprinting Market
13. Latin America 3D Bioprinting Market
14. MEA 3D Bioprinting Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
- Organovo Holdings Inc. (U.S.)
- Desktop Metal (U.S.)
- Poietis (France)
- Inventia Life Science Pty Ltd. (Australia)
- VIVAX BIO
- LLC (U.S.)
- Cyfuse Biomedical K.K. (Japan)
- Allevi (U.S.)
- CELLINK (U.S.)
- Aspect Biosystems Ltd. (Canada)
- EnvisionTEC (Germany)
For more information about this report visit https://www.researchandmarkets.com/r/bpwur9
View source version on businesswire.com:https://www.businesswire.com/news/home/20221128005398/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH HEALTH TECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/28/2022 07:12 AM/DISC: 11/28/2022 07:13 AM
http://www.businesswire.com/news/home/20221128005398/en
